2 news items
MAIA Biotechnology (MAIA): Pioneering New Frontiers in NSCLC Treatment with THIO
BMRN
EXEL
GMAB
7 Jun 24
and stakeholders are encouraged to visit the poster session details and other company presentations available on MAIA’s website
MAIA Biotechnology (NYSE: MAIA) Makes Strategic Moves: Key Presentations, New Funding, and Leadership Changes Drive Innovation
ABBV
JNJ
LLY
21 May 24
to present at the BIO International Convention, a prestigious event that attracts key stakeholders from the biotech and pharmaceutical industries. According
- Prev
- 1
- Next